Hyperhidrosis Treatment Market Report 2025 (Global Edition)

Global Hyperhidrosis Treatment Market Report 2025 Market Size Split by Type (Axillary hyperhidrosis, Palmar hyperhidrosis, Plantar hyperhidrosis, Others), by Treatment (Botulinum toxin injections, Top...

Hyperhidrosis Treatment Market Report Description

We have various report editions of Hyperhidrosis Treatment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Hyperhidrosis Treatment Market Insights Video

Competitive Landscape of the Hyperhidrosis Treatment Market

Leading market players are extensively spending in R&D to extend their product lines, allowing the hyperhidrosis treatment market to grow even more. Market participants are also engaging in a number of strategic initiatives to expand their presence, with significant market developments including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. To grow and survive in a more competitive and increasing market environment, the hyperhidrosis treatment sector must provide cost-effective products.

In October 2022, Candesant Biomedical developed the "SweatTech Initiative" to increase awareness about the seriousness of hyperhidrosis, provide information on how therapies have evolved, and highlight the continued need for more modern treatments. This emphasized both the limitations of conventional medicines and the possibilities of Candesant's unique approach. (Source: https://practicaldermatology.com/news/candesant-biomedical-novel-investigational-technology-for-hyperhydrosis/2461371/) In May 2022, Maruho Co., Ltd. introduced Rapifort wipes 2.5% in Japan to treat primary axillary hyperhidrosis. This product launch enabled the company to expand its product offering. (Source: https://www.maruho.co.jp/english/information/20220523.html)

Top Companies Market Share in Hyperhidrosis Treatment Industry: (In no particular order of Rank)

• AbbVie Inc.
• Avanor Healthcare Ltd.
• Brickell Biotech Inc.
• Dermadry Laboratories Inc.
• Dermavant Sciences Inc.
• Hugel
• Inc.
• Eirion Therapeutics
• Inc
• Eli Lilly and Company
• Intas Pharmaceuticals Ltd
• Kaken Pharmaceutical Co.
• Ltd.
• Maruho Co.
• Ltd.
• miraDry
• Inc.
• SweatBlock
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Hyperhidrosis Treatment Market

Which Region Dominates the Hyperhidrosis Treatment Market in 2024?

According to Cognitive Market Research, North America dominated the worldwide hyperhidrosis treatment market in 2023 and is expected to continue to do so during the forecast period. This is due to technological improvements in hyperhidrosis treatment, a high incidence of disease, and the availability of critical and robust medical infrastructure in the region.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Hyperhidrosis Treatment market due to an increase in patient population, the development of healthcare infrastructure, and an increase in regional investment projects.

The current report Scope analyzes Hyperhidrosis Treatment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Hyperhidrosis Treatment Market Analysis

According to Cognitive Market Research, the global Hyperhidrosis Treatment market size was estimated at USD 615.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 246.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Hyperhidrosis Treatment market with a market size of USD 194.28 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. The nation's high prevalence of hyperhidrosis among the population.
• The Canada Hyperhidrosis Treatment market had a market share of USD 29.55 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. Canada's Hyperhidrosis Treatment market is experiencing growth due to increasing awareness of the condition and the availability of various treatment options.
• The Mexico Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 22.41 million in 2024.

Europe Hyperhidrosis Treatment Market Analysis

According to Cognitive Market Research, the global Hyperhidrosis Treatment market size was estimated at USD 615.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 184.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031.

• The United Kingdom Hyperhidrosis Treatment market had a market share of USD 31.03 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. In the UK, Hyperhidrosis Treatment sales witnessed an upswing due to the increasing recognition of hyperhidrosis as a medical condition that significantly impacts quality of life.
• The France Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 16.99 million in 2024.
• According to Cognitive Market Research, the German Hyperhidrosis Treatment market size was valued at USD 36.57 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. In Germany, Hyperhidrosis Treatment surged due to the availability of advanced therapies.
• The Italy Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD 15.88 million in 2024.
• The Russia Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 28.63 million in 2024.
• The Spain Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 15.14 million in 2024
• The Luxembourg Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 5.73 million in 2024.
• The Portugal Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 3.88 million in 2024.
• The Greece Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 2.22 million in 2024.
• Rest of Europe's Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 28.63 million in 2024.

Asia Pacific Hyperhidrosis Treatment Market Analysis

According to Cognitive Market Research, the global Hyperhidrosis Treatment market size was estimated at USD 615.6 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 141.59 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Hyperhidrosis Treatment market size was valued at USD 63.71 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Hyperhidrosis Treatment surged in China due to the increasing prevalence of the condition and a growing awareness of its impact on daily life.
• The Japan Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 19.54 million in 2024.
• The India Hyperhidrosis Treatment market had a market share of USD 16.99 million in 2024 and is projected to grow at a CAGR of 9.3% during the forecast period. India's increasing awareness of hyperhidrosis as a medical condition.
• The South Korean Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 14.16 million in 2024.
• The Australian Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 7.36 million in 2024.
• The South East Asia Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 9.77 million in 2024.
• The Rest of Asia Pacific Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 10.05 million in 2024.

South America Hyperhidrosis Treatment Market Analysis

According to Cognitive Market Research, the global Hyperhidrosis Treatment market size was estimated at USD 615.6 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 30.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Hyperhidrosis Treatment market size was valued at USD 13.17 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Hyperhidrosis Treatments flourished in Brazil due to the availability of advanced treatment options
• Argentina's Hyperhidrosis Treatment market had a market share of USD 5.17 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. Argentina's technological advancements.
• Colombia Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 2.74 million in 2024.
• Peru Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 2.52 million in 2024.
• Chile Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 2.22 million in 2024.
• The Rest of Latin America's Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 4.96 million in 2024.

Middle East Hyperhidrosis Treatment Market Analysis

According to Cognitive Market Research, the global Hyperhidrosis Treatment market size was estimated at USD 615.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 12.31 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031..

• The GCC Countries Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 5.27 million in 2024. Hyperhidrosis Treatment sales flourish due to the increasing awareness of the condition.
• The Egypt Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 1.29 million in 2024.
• The South Africa Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 1.95 million in 2024. Hyperhidrosis Treatment sales flourish in South Africa due to improvements in healthcare infrastructure and dermatological services
• The Turkey Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 1.06 million in 2024.
• The Nigeria Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 1.29 million in 2024.
• The Rest of MEA Hyperhidrosis Treatment market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 1.45 million in 2024.

Hyperhidrosis Treatment Market Analysis

Hyperhidrosis Treatment Market Type Segment Analysis

According to Cognitive Market Research, Axillary hyperhidrosis stands out as the dominant category over the projected period. The axillary hyperhidrosis sector benefits from a diverse set of effective treatment options that are widely available and accepted by both patients and healthcare providers. Topical antiperspirants, botulinum toxin injections (like Botox), and microwave thermolysis (like MiraDry). This drives the expansion of the axillary hyperhidrosis segment.

Palmar hyperhidrosis is thus the fastest-growing segment of the Hyperhidrosis Treatment Market. This excessive sweating in palms is such that it mortifies daily activities and hence social interactions; therefore, many such patients seek effective treatments. Growing awareness about the condition and new treatments like Botox injections and minimally invasive procedures has fueled its growth.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Hyperhidrosis Treatment Industry. Request a Free Sample PDF!

Hyperhidrosis Treatment Market Treatment Segment Analysis

According to Cognitive Market Research, botulinum toxin A is expected to dominate the global market. In 2004, the US Food and Drug Administration (FDA) approved BOTOX (onabotulinumtoxinA) to treat severe primary axillary hyperhidrosis. Aquavit Holdings LLC has secured the sole license to register, distribute, and market a botulinum toxin in the United States and Canada, according to information released in April 2021

The fastest-growing category in the Hyperhidrosis Treatment market is Topical treatment. Topical treatments, like as antiperspirants, are widely available over the counter, making them a first-choice treatment for many people. Their simplicity enables patients to administer these therapies directly to the damaged areas without the need for medical supervision, making them appealing to a wide range of audiences.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Hyperhidrosis Treatment Age Segment Analysis

Hyperhidrosis Treatment Market Age Segment Analysis

According to Cognitive Market Research, the below 50 age group has the biggest market share, owing to the higher frequency of illness in this population.

The above 50 years subsegment is the fastest growing segment in the Hyperhidrosis Treatment Market, owing to increased awareness and recognition of hyperhidrosis as a medical issue, resulting in more people seeking remedies. Excessive sweating can have a negative influence on everyday activities and self-esteem. Therefore, demand is driven by the desire to improve the quality of life and social interactions.

• Below 50 years
• Above 50 years

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion